In order to examine the effects of molecular signaling on DCIS, we tested the model in the case of both high and low signaling thresholds for both estrogen (upregulating ER+ cell proliferation) and FGF (upregulating ER− cell proliferation). The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.